Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients
Clinical trial NCT00952003 · COMPLETED
Trial details
- NCT number
- NCT00952003
- Sponsor
- Arbeitsgemeinschaft medikamentoese Tumortherapie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2014-10-22
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.